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Abstract
Spinster homolog 2 (Spns2) acts as a Sphingosine-1-phosphate (S1P) transporter in zebrafish and mice, regulating heart
development and lymphocyte trafficking respectively. S1P is a biologically active lysophospholipid with multiple roles in
signalling. The mechanism of action of Spns2 is still elusive in mammals. Here, we report that Spns2-deficient mice rapidly
lost auditory sensitivity and endocochlear potential (EP) from 2 to 3 weeks old. We found progressive degeneration of
sensory hair cells in the organ of Corti, but the earliest defect was a decline in the EP, suggesting that dysfunction of the
lateral wall was the primary lesion. In the lateral wall of adult mutants, we observed structural changes of marginal cell
boundaries and of strial capillaries, and reduced expression of several key proteins involved in the generation of the EP
(Kcnj10, Kcnq1, Gjb2 and Gjb6), but these changes were likely to be secondary. Permeability of the boundaries of the stria
vascularis and of the strial capillaries appeared normal. We also found focal retinal degeneration and anomalies of retinal
capillaries together with anterior eye defects in Spns2 mutant mice. Targeted inactivation of Spns2 in red blood cells,
platelets, or lymphatic or vascular endothelial cells did not affect hearing, but targeted ablation of Spns2 in the cochlea
using a Sox10-Cre allele produced a similar auditory phenotype to the original mutation, suggesting that local Spns2
expression is critical for hearing in mammals. These findings indicate that Spns2 is required for normal maintenance of the
EP and hence for normal auditory function, and support a role for S1P signalling in hearing.
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Introduction
Spinster homolog 2 (Spns2) is a multi-pass membrane protein
belonging to the Spns family. Though the functions of Spns1 and
Spns3 are largely unknown, Spns2 is known to act as a
sphingosine-1-phosphate (S1P) transporter, based upon previous
studies in zebrafish and mouse [1–6]. S1P is a vital lipid. It has
diverse roles, functioning as a signalling molecule regulating cell
growth [7,8], programmed cell death [9], angiogenesis [10,11],
vascular maturation [12,13], heart development [14] and immu-
nity [15,16] by binding specific G-protein-coupled S1P receptors.
Red blood cells and endothelial cells are important sources of
circulating S1P [17–19]. The role of Spns2 in regulating S1P
signalling is still elusive.
Spns2-deficient mice were initially discovered to be deaf during
a large-scale screen of new mouse mutants carried out by the
Sanger Institute’s Mouse Genetics Project (MGP). The MGP uses
the KOMP/EUCOMM resource of over 15,000 genes targeted in
embryonic stem (ES) cells and aims to generate new mutants and
screen them for a wide range of diseases and traits to reveal the
function of 160 mutant genes each year [20]. Screening of hearing
using the Auditory Brainstem Response (ABR) is part of the
standardised battery of primary phenotypic tests and is carried out
at 14 weeks of age [20]. Mutants generated from the KOMP/
EUCOMM ES cell resource normally carry LoxP and Frt sites
(Fig. 1A) engineered to facilitate further genetic manipulation to
generate the conditional allele and then to knock out gene
expression selectively [21].
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Spns2-deficient mice showed early onset of hearing loss that
progressed rapidly to profound deafness. This was associated with
declining endocochlear potential (EP), which appeared to be the
primary physiological defect. At later stages we observed
degeneration of sensory hair cells and decreased expression of
several key genes required for normal generation of the EP in the
lateral wall of the cochlea, but these appeared to be secondary
effects. By producing and analysing different conditional knock-
outs, we established that Spns2 expression was required locally in
the inner ear rather than systemically. Our study suggests a vital
role for Spns2 and S1P signalling in hearing.
Results
Spns2 gene targeting and mouse production
The introduction of a cassette with an additional splice acceptor
site is predicted to interrupt normal transcription of the Spns2 gene
(Fig. 1A) and generate a truncated non-functional transcript
encoding the first 146 out of 549 amino acids of the Spns2 protein
[4]. The Spns2tm1a/tm1a mice were fertile and can survive to
adulthood, but were born at sub-Mendelian ratios (15.9%
homozygotes among 747 offspring of heterozygous intercrosses;
x2 test, p,0.001). Quantitative real-time PCR revealed that
residual transcript of Spns2 in cochleae, eyes and livers of the
homozygous mice was substantially reduced compared to that of the
heterozygous and wildtype mice (Fig. 2A). In order to completely
inactivate expression of the Spns2 gene, we produced Spns2tm1b/tm1b
mice by crossing Spns2tm1a/tm1a with mice ubiquitously expressing
Cre recombinase to delete exon 3 in the germline. Spns2tm1b/tm1b
mice were also fertile and can survive to adulthood with a birth
rate at sub-Mendelian ratios (16.9% homozygotes among 266
offspring of heterozygous intercrosses; x2 test, p=0.0044). In
other aspects of their phenotype, Spns2tm1b/tm1b mice were
broadly similar to Spns2tm1a/tm1a mice (see http://www.sanger.
ac.uk/mouseportal/search?query=spns2 for a comparison of the
two lines). Spns2tm1a/tm1a mice were the first to be available and
were used for most experiments in this study, and may be more
relevant to human disease because most disease-causing
mutations reduce rather than eliminate gene activity.
Spns2tm1a/tm1a mice have early onset progressive hearing
impairment
We found that Spns2tm1a/tm1a mice had profound hearing
impairment during screening at 14 weeks old by auditory
brainstem response (ABR) measurement (Fig. 1D). Spns2tm1a/tm1a
mice displayed no overt signs of abnormal behaviour throughout
life up to 12 months old (n = 20 homozygotes, 29 control
littermates) suggesting normal vestibular function. ABR measure-
ments were recorded at younger ages to find out the time of onset
of hearing loss. Hearing impairment in Spns2tm1a/tm1a mice can
be detected as early as 2 weeks of age at high frequencies
(Fig. 1B, E, G), and thresholds were raised further at a wide
range of frequencies by 3 weeks old (Fig. 1C, F, G). The mutant
thresholds recorded at P21 were significantly elevated compared
with mutant thresholds at P14, indicating progressive hearing loss
(Kruskall-Wallis One-Way Analysis of Variance on ranks,
H= 102.857, 17 degrees of freedom, p,0.001). There was no
difference in ABR thresholds between the Spns2+/tm1a and
Spns2+/+ mice, indicating recessive inheritance. Thresholds
continue to improve in control mice from 2 to 3 weeks old as
hearing function matures [22].
Spns2 is expressed in the inner ear
Quantitative real-time PCR showed that Spns2 is expressed in
the cochlea, both in the lateral wall and organ of Corti, and in eyes
and liver in P4 wildtype mice (Fig. 2A). X-gal staining was used to
indicate expression domains of Spns2, benefiting from the
knockout first design of the allele which includes a LacZ reporter
gene (Fig. 1A). At P10, X-gal labeling was detected in the spiral
prominence area (Fig. 2C), hair cells (Fig. 2D), Reissner’s mem-
brane (Fig. 2B), vessels of inner ear (Fig. 2E) including the spiral
modiolar vessels (Fig. 2F), proximal auditory nerve and bony shell
of the cochlea (Fig. 2B), and the stria vascularis close to where the
Reissner’s membrane attaches. There was a similar labelling
pattern at P14. The X-gal staining was also detected in the
maculae and cristae in the vestibular system (Fig. S1A,B). On the
basis of the expression pattern, our further investigation focused on
two key components of the inner ear: the organ of Corti, where the
pressure wave is transduced into action potentials, and the lateral
wall, which maintains the ionic homeostasis of the cochlear
endolymph.
Progressive degeneration of organ of Corti
The Spns2tm1a/tm1a mice showed a normal gross morphology of
the middle ear and ossicles assessed by dissection and gross
inspection, and the cleared inner ears also showed no malforma-
tion (Fig. S1C,D). We performed scanning electron microscopy
(SEM) of P4, P21, P28 and P56 Spns2tm1a/tm1a mice and littermate
controls. The hair cells of Spns2tm1a/tm1a mice appeared normal at
P4 (Fig. S1E,F) and at P21 (Fig. 3A,B). There was scattered or
patchy degeneration of stereocilia of outer hair cells in the
homozygous cochleae at P28 (Fig. 3C,D). Hair cell degeneration
became more apparent over time and by P56, only a few outer
hair cells remained at the apex with most of them missing in other
turns, and inner hair cells showed signs of degeneration such as
fused stereocilia (Fig. 3E,F).
We also used transmission electron microscopy to examine the
cochlear duct at P28, and observed degeneration of the basal turn
organ of Corti and an apparently reduced density of dendrites in
Rosenthal’s canal in that turn (see later).
The increase in ABR thresholds preceded degeneration of the
organ of Corti suggesting that these were secondary changes rather
than the primary cause of the hearing impairment.
Author Summary
Progressive hearing loss is common in the human
population but we know very little about the molecular
mechanisms involved. Mutant mice are useful for investi-
gating these mechanisms and have revealed a wide range
of different abnormalities that can all lead to the same
outcome: deafness. We report here our findings of a new
mouse line with a mutation in the Spns2 gene, affecting
the release of a lipid called sphingosine-1-phosphate,
which has an important role in several processes in the
body. For the first time, we report that this molecular
pathway is required for normal hearing through a role in
generating a voltage difference that acts like a battery,
allowing the sensory hair cells of the cochlea to detect
sounds at extremely low levels. Without the normal
function of the Spns2 gene and release of sphingosine-1-
phosphate locally in the inner ear, the voltage in the
cochlea declines, leading to rapid loss of sensitivity to
sound and ultimately to complete deafness. The human
version of this gene, SPNS2, may be involved in human
deafness, and understanding the underlying mechanism
presents an opportunity to develop potential treatments
for this form of hearing loss.
Spns2 Deficiency Causes Hearing Loss
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Decreased endocochlear potential (EP) in Spns2tm1a/tm1a
mice
The stria vascularis is responsible for pumping K+ into the
endolymph and generation of the endocochlear potential (EP)
[23]. The EP starts to develop at around P6 in the mouse reaching
adult values around P16 [24] and plays a key role in sound
transduction because it provides approximately half of the
electrochemical gradient that drives cations from the endolymph,
a K+-rich extracellular fluid, into the sensory hair cells through
mechanoelectrical transduction channels. The lateral wall of the
cochlea is composed of the stria vascularis, spiral prominence and
the spiral ligament. A defect in the function of any of these
components could interfere with the generation of the EP.
Therefore, we measured the EP to evaluate the function of the
Figure 1. Generation and manipulation of the knockout-first allele Spns2tm1a and progressive hearing loss measured by ABR. A, The
promoter-driven cassette, including a splice acceptor site, an internal ribosome entry site (IRES) and a b-galactosidase reporter (lacZ), followed by a
neomycin resistance marker expressed from an independent b-actin promoter, was inserted into intron2 of the Spns2 gene. FRT sites surround the
inserted cassette and LoxP sites flank the critical exon (exon 3 of Spns2; http://www.knockoutmouse.org/martsearch/project/25171). The lacZ-tagged
Spns2tm1b allele was generated by breeding Spns2tm1a-carrying mice to mice expressing Cre recombinase driven by the CMV promoter, to delete the
floxed critical exon and the neomycin-containing promoter-driven selection cassette. Flp-mediated recombination removed the main inserted
cassette to convert the knockout-first allele (Spns2tm1a) to Spns2tm1c, restoring Spns2 gene activity. Cre recombination driven by a suitable promoter
such as the Sox10-Cre allele deleted the floxed exon 3 of the Spns2tm1c allele to generate a frameshift mutation (Spns2tm1d), triggering nonsense
mediated decay of the transcript. B,C Spns2tm1a/tm1a mice showed progressive hearing impairment between 2 and 3 weeks of age. Raised mean ABR
thresholds were detected as early as 2 weeks old in Spns2tm1a/tm1a mice (red, +/2 SD), mainly from 24 kHz to 42 kHz with thresholds 30–40 dB higher
than those of control mice (Spns2+/+, n = 10; Spns2+/tm1a, n = 16; Spns2tm1a/tm1a, n = 5). At 3 weeks old, hearing impairment became worse and all the
frequencies were affected (Spns2+/+, n = 14; Spns2+/tm1a, n = 16; Spns2tm1a/tm1a, n = 13). Heterozygotes in blue; wildtypes in green; pale gray lines show
thresholds of individual mutant mice. In C, the 2 week old mean mutant thresholds are plotted in pink with open circles for comparison with 3 week
old data, indicating significant progression of the hearing loss (Kruskall-Wallis One-Way Analysis of Variance on Ranks H= 102.857, 17 degrees of
freedom, p,0.001). D, Mean ABR thresholds of mutants (red) at 14 weeks old (n = 6, pale gray symbols represent individual mice) showed either very
raised ABR thresholds or no response at all at the maximum sound level used (95 dB SPL). The green area shows the reference range for thresholds of
wildtype mice of the same genetic background (n = 440), plotting the median and 2.5% to 97.5% percentiles. E,F, ABR thresholds of individual
Spns2tm1a/tm1a and wildtype mice. Arrows at top indicate no response at the plotted maximum sound pressure level used. Heterozygous data are
comparable to those of wildtypes (green) and not shown here. G, Mean thresholds of mutants at 2 weeks (red), 3 weeks (brown) and 14 weeks (gray)
are shown plotted as the difference between mutant and wildtype (green) thresholds, showing an increasing difference between 2 and 3 weeks,
partly due to increasing thresholds of mutants (see B and C) and partly due to continuing maturation of thresholds of wildtypes.
doi:10.1371/journal.pgen.1004688.g001
Spns2 Deficiency Causes Hearing Loss
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lateral wall. The EP values of the control mice were normal,
around 99 to 120 mV, which matched their normal hearing.
Spns2tm1a/tm1a mice had abnormally low EP values of 2 to 41 mV
at both P21 and P28 when they were profoundly deaf (Fig. 4).
However, at P14 the EP was higher, ranging from 52 to 107 mV,
with some measurements within the normal range, corresponding
to the partially preserved hearing at that age (Fig. 1C). The EP
appeared to develop to near-normal levels and then declined very
rapidly between P14 and P21. These data indicate that the cause
of hearing loss in Spns2tm1a/tm1a mice is a failure to maintain the
normal level of the EP after it develops, suggesting that the
primary lesion is more likely to be in the lateral wall than the organ
of Corti.
Structural defects of the stria vascularis
In order to understand what causes the reduction in the EP, we
investigated the lateral wall, where the EP is produced. Generation
of a voltage difference requires efficient separation of different
compartments within the cochlear duct with adequate electrical
resistance. Therefore we examined the morphology of cell
boundaries between adjacent marginal cells and between basal
cells in whole-mount samples of the stria vascularis. Filamentous
actin was stained by phalloidin to label the cell boundaries at
different ages. At P14, both wildtype and homozygous mice
showed a distinctive regular hexagonal pattern of the boundaries
of marginal cells (Fig. 5A,B). At P28, a subtle change was seen in
Spns2tm1a/tm1a mice (Fig. 5C) and it became worse with age with a
patchy pattern of different layouts of cell boundaries (Fig. 5D,E).
However, the boundaries were always continuous and intact in
Spns2tm1a/tm1a mice without any sign of breakdown (Fig. 5C–E).
We quantified the marginal cell numbers by using the labelled cell
boundaries at P28. The density of marginal cells in Spns2tm1a/tm1a
mice was reduced compared with controls (t test, p,0.05),
associated with irregular layout of marginal cell boundaries
(Fig. 5J). Noticeably, this irregularity of marginal cells was not
detected in mutants at P14, a stage when hearing had started to
deteriorate, but appeared at later stages. The boundaries between
basal cells of the stria vascularis did not show any obvious
anomalies in mutants (Fig. S2A,B).
The morphology of strial capillaries was examined as well.
Some Spns2tm1a/tm1a mice showed slight dilation (2 out of 5 mice)
in patches along the length of the cochlear duct, and apparently
increased branching (Fig. 5H) at P14. At P28, these changes were
detected in all five tested mice and were more severe than at P14
although were still patchy (Fig. S2C,D). The number of branch
points per unit area in homozygotes was significantly more than
that in the control mice (Mann-Whitney Rank Sum Test, p,0.05
at both P14 and P28; Fig. 5I).
We analysed the structure of the lateral wall of the cochlea,
including the stria vascularis and spiral ligament, using semithin
sections and transmission electron microscopy in P28 mice. The
position of Reissner’s membrane was normal in semi-thin sections
of P28 cochleae (Fig. 6A,B), with no evidence of hydrops or
collapse. No systematic differences in the appearance of fibrocytes
of the spiral ligament were observed (Fig. 6C,D). The inner
boundaries of marginal cells of the stria, facing the endolymph,
have a typical scallop-shaped surface in wildtype mice with the
junctions between adjacent cells raised, but this feature was not
Figure 2. Spns2 is expressed in the cochlea. A, Quantitative real time PCR showed that Spns2 is expressed in the cochlea (OC: organ of Corti, LW:
lateral wall) and other organs including the eye, and a small amount of residual transcript remained in the homozygotes (red), ranging from 8% to
22% of wildtype (green) levels. Blue represents heterozygotes. B, X-gal staining showed expression of Spns2 in the cochlea in a homozygote at P10.
Labelling (blue) was detected in the spiral prominence area (B,C), hair cells (B,D), Reissner’s membrane, blood vessels in lateral wall (B,E), modiolar
vessels (F), and bony shell (B). Labelling was also seen in the central projection of the auditory nerve (not shown). Nuclei are labelled in red. Scale bar:
50 mm in C, 20 mm in D,E,F,G.
doi:10.1371/journal.pgen.1004688.g002
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seen in the Spns2tm1a/tm1a mice and the luminal surface appeared
flat (Fig. 6E,F). Nuclei of marginal and basal cells appeared more
rounded in Spns2tm1a/tm1a mice than in wildtypes (Fig. 6E,F).
There was also a marked difference in the appearance of
endothelial cells and pericytes [25,26] of strial capillaries, with
the nuclei of mutant cells appearing more darkly-stained
(Fig. 6G,H). However, this abnormality appeared to be limited
to capillaries of the stria vascularis only, and was not seen in the
spiral ligament capillaries (Fig. 6I), suggesting a specific effect of
Spns2 deficiency on the capillaries of the stria vascularis.
Intermediate cells of the stria vascularis are derived from
melanocytes and tend to accumulate pigment during ageing or
under stress such as in mice with Pendrin deficiency [27,28]. The
pigmented cells may derive from migratory melanocytes that
adopt macrophage-like features during development [27,29] or
may derive from macrophage invasion [28]. At 4 weeks of age, we
did not observe any obvious difference in strial pigmentation
between Spns2 mutants and control littermates, but by 7 months
old the mutant strias appeared more strongly pigmented than
controls (Fig. S2E,F). This timecourse, after the onset of raised
thresholds, suggests the accumulation of pigment is likely to be a
secondary effect, not a cause of cochlear dysfunction.
Normal strial integrity and normal permeability of strial
capillaries to BSA-FITC
In view of the abnormal morphology of marginal cell
boundaries, we asked whether the diffusion barrier of stria
vascularis, for example between adjacent marginal cells, was
affected because normal morphology of boundaries at P14 does
not necessarily mean normal function. We used biotin as a tracer
injected into the endolymphatic and perilymphatic compartments
of 6 week old mice to test the barrier permeability of the stria
vascularis. There was no evidence of biotin entry into the stria
vascularis of Spns2tm1a/tm1a or control mice indicating a normal
diffusion barrier of stria vascularis (Fig. 7A,B). As we observed
dilated strial capillaries with abnormal endothelial cells and
pericytes, we tested their permeability by injecting BSA-FITC
into the tail vein. There were no signs of leakage of the tracer to
the tissues surrounding the strial capillaries in Spns2tm1a/tm1a mice
suggesting that they have normal permeability to BSA-FITC
(Fig. 7C,D).
Decreased expression of Kcnj10, Kcnq1, Gjb2 and Gjb6 in
lateral wall
To further investigate the reasons underlying the reduced EP
and deafness in the Spns2 tm1a/tm1a mice, we analysed expression of
some key proteins involved in normal EP formation and
maintenance by immunofluorescence labelling, including Kir4.1
(Kcnj10), Kv7.1 (Kcnq1), Cx26 (Gjb2), Cx30 (Gjb6), Na+, K+-
ATPase (Atp1a1), NKCC1 (Slc12a2) and ZO-1 (Tjp1). In
homozygotes aged P14 (Fig. 8F,G,J,K,N,O), the expression of
these proteins appeared normal, apart from the expression of
Kcnj10, which appeared normal in most mutants (5/8), with the
remaining three mice showing reduced labelling in the basal turn
only (Fig. 8A–C). At 5–6 weeks old, we observed similar
expression of Na+/K+-ATPase, NKCC1 and ZO-1 in Spns2
tm1a/tm1a mice compared with control mice (Fig. S3A–F). However,
the other four proteins showed reduced expression at this age and
the expression of Kcnj10 was largely absent in the stria vascularis
(Fig. 8D,E). In contrast, there was similar labelling intensity of
Kcnj10 in the satellite cells of the spiral ganglion in mutants and
control mice (Fig. S3G,H). The expression of Kcnq1 appeared to
be evenly distributed on the luminal surface of marginal cells in
both wildtype and homozygotes at P14 (Fig. 8F, G), but at 5–6
weeks, labelling of Kcnq1 in the homozygotes was absent in some
Figure 3. Progressive deterioration of hair cells shown by
scanning electron microscopy. Spns2tm1a/tm1a mice have a normal
structure of hair bundles compared with wildtype mice at P21 (A,B).
Scattered or patchy outer hair cell (OHC) degeneration was observed in
the middle turn at P28 (C,D). Most stereocilia of OHCs in basal and
middle turn have degenerated and stereocilia of IHCs were fused or lost
at P56 (E,F). All the images were taken from the middle turn of the
cochlea, defined as 40–70% of the distance along the cochlear duct
from the base. Scale bar: 10 mm.
doi:10.1371/journal.pgen.1004688.g003
Figure 4. Endocochlear potential (EP) showed a progressive
reduction from P14 to P21. Control mice had normal EP magnitudes
of around 99–120 mV at P14 (Spns2+/+, n = 4; Spns2+/tm1a, n = 9), P21
(Spns2+/+, n = 3; Spns2+/tm1a, n = 3) and P28 (Spns2+/+, n = 4; Spns2+/tm1a,
n = 5). The Spns2tm1a/tm1a mice showed a significant reduction in the EP
magnitude at P14 (n = 11; p,0.001), P21 (n = 6; p = 0.002) and P28
(n = 12; p,0.001) compared to age-matched control values (Mann-
Whitney Rank Sum Test; SigmaPlot v12.0). There was a large drop in the
EP values in Spns2tm1a/tm1a mice between P14 and P21.
doi:10.1371/journal.pgen.1004688.g004
Spns2 Deficiency Causes Hearing Loss
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of the marginal cells that had enlarged boundaries (Fig. 8H,I).
There was extensive expression of Gjb2 and Gjb6 in fibrocytes
type I, II, and V of the spiral ligament in the wildtype
(Fig. 8J,L,N,P) and homozygotes (Fig. 8K,O), but expression
appeared greatly reduced behind the spiral prominence area
corresponding to the fibrocyte type II region [30] in the Spns2tm1a/
tm1a mice (Fig. 8M,Q) aged 5–6 weeks old. As EP started to reduce
at P14, while expression of Kcnj10 (in the majority of observed
mice), Kcnq1, Gjb2 and Gjb6 appeared normal at this age, these
findings suggest that the reduction in expression of these key
Figure 5. Disorganized marginal cell boundaries and abnormal strial capillaries. A–E, Morphological changes of marginal cell boundaries
with age. The marginal cell boundaries were visualised by phalloidin staining (red) in whole-mounts of stria vascularis. Normal morphology of the
marginal cell boundaries at P14 in both wildtype (A) and homozygous mice (B), and a subtle change in homozygous mice (C) at P28. D,E show the
further change with age in one 6-month old homozygous mouse, which displays variable changes along the length of the cochlear duct. DAPI (blue)
staining visualised the nuclei. More than one nucleus can be seen within the red-labelled boundaries. Images are taken from the middle turn (40–
70%) of the cochlear duct. Scale bar, 20 mm. F–H, Stria vascularis showed dilated capillaries and increased branching. Strial capillaries were visualised
by isolectin B4 (green). This change can be detected in patches in some mutants from P14 (H), but was variable (G and H). I, Branch point counting of
strial capillaries and comparison between homozygotes and controls at P14 and P28. The capillaries of homozygotes (red) at P14 (n = 5, P,0.05) and
P28 (n = 5, P,0.05) had significantly increased densities of capillary branching compared with those of controls (blue). Mann-Whitney Rank Sum Test;
SigmaPlot v12.0. J, Density of marginal cells in surface preparations of the stria vascularis in Spns2tm1a/tm1a (red, n = 4) and Spns2+/tm1a (blue, n = 4) at
P28 showed reduced density in mutants (t test, p,0.05).
doi:10.1371/journal.pgen.1004688.g005
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proteins in adults is secondary to a primary dysfunction of EP
generation.
Conditional knock-out of Spns2 suggests a local function
We generated the conditional allele of Spns2 (Spns2tm1c) by
crossing the Spns2tm1a allele to a line expressing Flp recombinase
to excise the inserted cassette (Fig. 1A). The Spns2tm1c/tm1c mice
have the same Spns2 allele as the wildtype except that exon 3 is
flanked by two loxP sites. Spns2tm1c/tm1c mice showed normal
ABR thresholds and normal morphology of hair cells (Fig. 9A, C).
These observations confirmed that the inner ear defects we found
in the Spns2tm1a/tm1a mice were due to the insertion of the cassette
and its disruption of Spns2 gene function.
We then asked whether the hearing defects of Spns2tm1a/tm1a
mice are caused by localised deficiency of Spns2 in the inner ear or
are mediated systemically. S1P is known to be released from
several other tissues that could affect cochlear function, including
various blood cell types and endothelial cells [1,2]. We generated
conditional knockout mice carrying the Spns2tm1d allele in specific
tissues by crossing mice carrying the Spns2tm1c allele with mice
carrying Cre recombinase under the control of five different
promoters: Tie1, Pf4, Lyve1, EpoR and Sox10, driving expression
of Cre recombinase in blood vessel endothelial cells, platelets,
lymphatic endothelial cells, red blood cells, and the inner ear with
surrounding neural crest-derived mesenchyme respectively.
Sox10-Cre transgenic mice have been successfully used to express
Cre recombinase in the developing inner ear previously [31].
Homozygous Spns2tm1d mutants carrying the Tie1, Pf4, Lyve1
and EpoR Cre alleles all had normal ABR thresholds in young
adults (Fig. 10). In contrast, no ABR response was detected in the
young adult Spns2tm1d/tm1d;Sox10-Cre mice (Fig. 10). Spns2tm1d/
tm1d; Sox10-Cre mice showed a similar pattern of progression of
raised thresholds between 2 and 3 weeks old as observed in
Spns2tm1a/tm1a mice (Fig. 11). Spns2tm1d/tm1d; Sox10-Cre mice also
Figure 6. Pathological changes in stria vascularis and normal
position of Reissner’s membrane. A,B In semi-thin sections (P28),
the position of Reissner’s membrane is not changed (bold arrow). Hair
cells and supporting cells of the most basal turn have degenerated
(open arrow). The neural dendrites in Rosenthal’s canal appeared
reduced (arrow). Scale bar: 100 mm. C and D are expanded views of the
areas framed in A and B and display similar morphology of fibrocytes in
mutants and controls. Scale bar 20 mm. By transmission electron
microscopy (P28, E–I), the normal scallop-shaped (bold arrow) luminal
boundary of marginal cells in control mice (E) was not found in the
Spns2tm1a/tm1a mice (F). Abnormalities were seen in nuclei of endothelial
cells (EC) and pericytes (PC) in strial capillaries of Spns2tm1a/tm1a mice
(G,H), which were not seen in the capillaries of spiral ligament (I) and
control strial capillaries (E). Scale bars: 10 mm in E,F, 2 mm in G–I.
doi:10.1371/journal.pgen.1004688.g006
Figure 7. Normal strial integrity and normal permeability of
strial capillaries to BSA-FITC. A,B, Endolymphatic and perilymphatic
compartments were perfused by Sulfo-NHS-LC-Biotin. Biotin was
detected by FITC-conjugated streptavidin (green) in frozen sections of
6 week old mice. No sign of biotin entry into the stria vascularis
compartment was found as shown by the arrow indicated that the tight
junctions of marginal and basal cells are sealed in Spns2tm1a/tm1a mice
(B) compared with the control mice (A). C,D, Stria vascularis capillaries
of young adult wildtype (C) and Spns2tm1a/tm1a (D) mice following BSA-
FITC injection into the tail vein, showing no evidence of leakage of the
tracer (green) out of the capillaries. The increased branching of
capillaries in these Spns2tm1a/tm1a mice is also visible. Scale bars,
20 mm in A–D.
doi:10.1371/journal.pgen.1004688.g007
Spns2 Deficiency Causes Hearing Loss
PLOS Genetics | www.plosgenetics.org 7 October 2014 | Volume 10 | Issue 10 | e1004688
showed similar inner ear pathological changes as found in
Spns2tm1a/tm1a mice, such as degeneration of hair cells (Fig. 9B,
D) and irregular arrangement of marginal cell boundaries.
Therefore, we propose that Spns2 plays an important role in
mammalian hearing through its localised function in the inner ear.
The Spns2tm1b/tm1b mutants, with deletion of exon 3 of Spns2,
showed a more severe increase in thresholds than the Spns2tm1a/tm1a
and Spns2tm1d/tm1d;Sox10-Cre mice from 2 weeks old, the earliest
stage studied, with a lack of detectable response at most frequencies
in most mice up to the maximum stimulus intensity used, 95 dB
SPL (Fig. 11, middle row).
Eye defects
Spns2tm1a/tm1a mice had other defects detected by the MGP
phenotyping pipeline such as low white blood cell count and
increased bone mineral density [4,20,32]. However, the eye
defects were of particular interest because of the relatively
common association of retinal defects with deafness, as in Usher
syndrome for example, and our finding of Spns2 expression in the
eye (Fig. 2A). We assessed the retina for features corresponding to
those found in the organ of Corti, and found focal degeneration of
the retina (Fig. 12D,E). As focal degeneration can be associated
with a Crb1rd8 mutant allele found in some C57BL/6 lines
[33], we sequenced this gene and confirmed that the Spns2
retinal phenotype was independent of the rd8 mutation. As the
Spns2tm1a/tm1a stria vascularis capillaries showed abnormal mor-
phology, we examined the retinal vasculature in whole mount
preparations. Retinal vein morphology also appeared abnormal
with some veins appearing thinner in mutants than in controls as
well as veins of irregular caliber (Fig. 12F–I). This retinal vascular
phenotype was first evident by P10 when the retinal vasculature
was still undergoing development, and persisted into adulthood.
We therefore undertook branchpoint analysis to quantify any
differences between Spns2tm1a/tm1a and Spns2+/tm1a mice. This
showed no difference between genotypes at P10 (Fig. 12J). We also
analysed the pericyte coverage of the retinal vessels, as a reduction
in pericyte coverage is associated with increased vascular
permeability. We found no significant difference in pericyte
coverage in peripheral vessels, and a small but significantly
reduced coverage in central vessels (Fig. S4A). The vitreous and
optic nerve appeared normal in the mutants (Fig. 12D,E).
Other eye defects included open eyelids at birth (Fig. S4B)
resulting in corneal opacity, vascularization and ulceration
(Fig. 12A,B,C). These corneal defects made retinal assessment by
ophthalmoscopy impossible in vivo. Histological examination
showed corresponding gross morphological defects. Eyes were
smaller, the cornea was thickened with vascularisation, the
anterior chamber was collapsed, and the lens was small and
cataractous (Fig. 12D,E). We observed the anterior eye defects in
the Spns2tm1a/tm1a and Spns2tm1b/tm1b mice, but these defects were
not seen in Spns2tm1d/tm1d;Sox10-Cre mice or any of the other four
conditional lines.
Discussion
Here, we report that Spns2-deficient (Spns2tm1a/tm1a) mice have
profound hearing loss and propose an underlying mechanism: a
rapid decline in EP paralleling loss of auditory sensitivity and
preceding degeneration of hair cells, suggesting that the primary
lesion is in the cochlear lateral wall, the site of EP production and
maintenance [23,34,35]. Reduced EP has been associated with ion
transport defects [36–39]; defects of tight junctions [40] or gap
junctions [41–43]; absence of melanocytes [24]; microvascular
disease [44,45]; abnormal spiral ligament development [35];
sphingomyelin metabolic disturbance [46], or the lateral wall
can simply be a target in systemic diseases [47]. This suggests
complexity underlying the strial/metabolic category of hearing
loss described in humans [48]. EP is essential for hair cell function
[49]. Degeneration of hair cells secondary to reduced EP has been
reported in other mouse mutants [50,51] and normal EP seems to
be important for survival of the hair cells. However, as Spns2 is
expressed in hair cells as well as in the lateral wall, we cannot
exclude the possibility that disruption of Spns2 function in the
organ of Corti also contributed to raised ABR thresholds and hair
cell degeneration. Analysis of mice with conditional knockout of
Spns2 in hair cells and other cochlear cell types will be useful in
dissecting the role of Spns2 further.
Spns2 acts as a transporter of S1P [1–6]. S1P may modulate
vascular tone [52] and has been shown to regulate the inner ear
spiral modiolar artery tone in vitro [53,54]. S1P-induced
vasoconstriction is thought to be important to protect strial
capillary beds from high pressure [54]. We found that Spns2 was
expressed in blood vessels of the inner ear including spiral
modiolar vessels. Any reduction in local S1P level due to Spns2
dysfunction may weaken vasoconstriction and explain the dilation
of strial capillaries in Spns2tm1a/tm1a mice. The relationship
between capillary size and EP value is not unidirectional; both
smaller and larger strial capillaries have been reported in different
mouse mutants with low EP [55,56]. S1P signalling also can affect
vascular permeability [57–59]. However, we did not see increased
permeability of strial capillaries using BSA as a tracer. Recently,
Mendoza and colleagues found little difference in lung vascular
permeability between Spns2-deficient and control animals [2],
similar to our finding in strial capillaries of Spns2tm1a/tm1a mice.
BSA is a medium molecular mass tracer (66.4 kDa), so tracers of
different sizes and properties such as Evans blue and cadaverine
[29] may be useful for further investigation of the strial capillary
barrier.
We found decreased expression of several proteins critical for
normal EP production at 5–6 weeks of age in Spns2-deficient
mice. However, the expression of most of these proteins appeared
normal at the time when the EP has already started to decline at
P14, suggesting that these are likely to be secondary effects. The
morphological changes of marginal cell boundaries and reduction
in marginal cell density together with a lack of expression of
Kcnq1 in affected cells are also likely to be secondary changes
because these features were normal when hearing started to
deteriorate at P14 and they did not affect strial permeability. Loss
of Kcnq1 expression in marginal cells with expanded luminal
surfaces may be a common consequence of strial dysfunction
because it has been reported in several different mutants with
reduced EP [28,46]. It has been suggested that these common
changes in mutant marginal cells may occur because these cells are
relatively sensitive to metabolic stress [60,61]. The variable
decrease in Kcnj10 labelling in the basal turn and slightly dilated
strial capillaries in a few mutants at P14 were the earliest
abnormalities we have seen, and may correlate with the variable
reduction in EP values at the same age. Disrupted expression of
Kcnj10 is another common consequence of strial dysfunction
[37,47,62]. The causal direction between reduced EP and
decreased Kcnj10 expression in Spns2-deficient mice needs
further investigation.
The most robust labeling for Spns2 expression was consistently
in the hair cells and spiral prominence. The function of the spiral
prominence is unclear. Two types of voltage-dependent K+
currents are expressed in spiral prominence epithelial cells, which
may play a role in the homeostasis of inner ear fluids [63]. Another
gene expressed strongly in the spiral prominence is pendrin (Pds),
Spns2 Deficiency Causes Hearing Loss
PLOS Genetics | www.plosgenetics.org 8 October 2014 | Volume 10 | Issue 10 | e1004688
and the Pds mutant mouse also shows reduced EP [64], loss of
expression of Kcnj10 [37] and Kcnq1 [28], and increased
accumulation of strial pigmentation compared with controls
[28]. However, the Pds mutant shows a severe early developmen-
tal defect of the inner ear with extensive hydrops [65], which we
do not find in Spns2 mutants. This indicates that Spns2-deficient
Figure 8. Progressive decrease in expression of Kcnj10, Kcnq1, Gjb2 and Gjb6 in Spns2tm1a/tm1a mice. A–E: At P14, Kcnj10 expression
(green) of homozygotes was comparable to that of wildtype in apical turns, while in basal turns, some appeared normal (B) as wildtype (A), but some
appeared largely reduced (C). At 5–6 weeks old, Kcnj10 labelling was absent in homozygotes (E). Acetylated a-tubulin (red) was used to label strial
marginal cells in D,E. F–I: Whole mount preparations of the stria. Kcnq1 labelling (green) was detected at P14 in both homozygotes (G) and wild types
(F), but it was absent from those marginal cells with enlarged cell boundaries in Spns2tm1a/tm1a mice at 5–6 wks (I). Phalloidin (red) labelled
filamentous actin to reveal the boundaries of marginal cells. J–Q: Gjb2 and Gjb6 were present in the fibrocytes of the spiral ligament in both wild type
and Spns2tm1a/tm1a mice at P14 (J,K,N,O). At 5–6 wks, expression was absent in the area behind the spiral prominence corresponding to the type II
fibrocytes in homozygotes (M and Q) compared with wildtypes (L and P) of the same age. Root cells were labelled by acetylated a-tubulin (red) in
P,Q. DAPI (blue) labelled the nuclei. Scale bar, 10 mm in D,E. 20 mm in A–C, F–I,P,Q. 50 mm in J–O.
doi:10.1371/journal.pgen.1004688.g008
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and Pds-deficient mice may have different mechanisms underlying
the reduced EP and hearing impairment. Dysfunction of the spiral
prominence in Spns2-deficient mice may be the main trigger of
reduction of the EP and a series of pathological changes in inner
ears.
One later change we saw in the lateral wall was a localised
decrease of Gjb2 and Gjb6 expression in the type II fibrocytes of
the spiral ligament located adjacent to the spiral prominence.
Type II fibrocytes are important for K+ recycling and are
considered to mediate K+ translocation between the epithelial cell
network of the organ of Corti and the fibrocyte network of the
lateral wall, and to facilitate ion flow directed towards the stria
vascularis [66]. Intriguingly, this reduction in expression was seen
for Gjb2 and Gjb6 only, and no reduction in labelling was found
of Atp1a1 and Slc12a2, two other proteins strongly expressed in
type II fibrocytes [67,68]. This may indicate a selective impact of
Spns2 deficiency on Gjb2 and Gjb6 expression in nearby cells, or
alternatively these two genes may be more sensitive to changes in
homeostasis in the cochlear duct than Atp1a1 and Slc12a2.
S1P is a bioactive lipid and acts as a second messenger
intracellularly and as a ligand for cell surface G protein-coupled
receptors extracellularly [69]. Five different S1P receptors
participate in cellular responses based on the cell type and
available downstream effectors [70]. S1P signalling has been
implicated in maintenance of hair cells via activation of S1P
receptor 2 (S1PR2) [71]. S1pr2-null mice are deaf and share some
pathological changes with Spns2-deficient mice, such as disorga-
nized cell boundaries of marginal cells, dilated capillaries in the
stria vascularis, and degeneration of the organ of Corti [54,71,72].
Unlike S1pr2-null or S1pr2/S1pr3 double null mice, no overt
vestibular defects were found in Spns2-deficient mice. Thus, we
propose that the Spns2-S1P-S1PR2 signalling axis is important for
normal hearing function. A similar Spns2-S1P-S1PR2 signalling
axis may exist in bones as both S1pr2-deficient [73] and Spns2-
deficient [32] mice have strong but brittle bones with high bone
mineral density. In contrast, the Spns2-S1P-S1PR1 signalling axis
is more important for lymphocyte trafficking [1–5].
Systemic disruption of Spns2 function in blood vessel or
lymphatic endothelial cells, platelets or red blood cells did not
affect hearing, suggesting that systemic loss of Spns2 activity in
these tissues does not mediate the hearing loss we see in the
Spns2tm1a mutants. However, when we deleted Spns2 locally in
the inner ear using the Sox10-Cre recombinase, the resulting
mutants were deaf. Sox10 is expressed throughout the otic
epithelium from an early stage of development as well as in
cranial neural crest-derived cells, so can effectively drive deletion
of exon 3 of the Spns2tm1c allele in the entire inner ear [74,75].
These findings indicate that hearing loss in Spns2tm1a/tm1a mice is
due to local loss of Spns2 function in the inner ear.
Defects of the anterior eye were only seen in the Spns2tm1a and
Spns2tm1b homozygous mutants. We did not see anterior eye
defects in any of the 5 conditional alleles, consistent with normal
anterior eye development in another conditional Spns2;Tie2-Cre
mutant mouse [1]. The anterior eye phenotype appears to be due
to a developmental abnormality resulting in defective eyelid
formation and subsequent corneal opacity and vascularisation.
Figure 9. ABR thresholds and SEM assessment suggest a local function of Spns2 in the inner ear. ABR thresholds (means +/2SD) are
shown for homozygotes (red), heterozygotes (blue) and wildtypes (green), aged 7–14 weeks. Mice homozygous for the Spns2tm1a allele displayed
elevated ABR thresholds and degeneration of hair cells (A left, 4 wks and B). By crossing with mice expressing Flp recombinase to excise the inserted
cassette, Spns2tm1c/tm1c mice were produced, which had normal ABR thresholds and normal hair cell morphology (A middle, 8 wks and C). Then
Spns2tm1c/tm1c were crossed with Sox10-Cre mice to produce Spns2tm1d/tm1d;Sox10-Cre mice which showed no response up to 95 dB SPL and hair cell
degeneration with bulges and holes in the reticular lamina (A right, 4 wks and D). SEM images are taken from the middle turn (40–70%) of the
cochlea. Scale bar: 10 mm in B,C,D.
doi:10.1371/journal.pgen.1004688.g009
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Spns2 also plays a role in retinal blood vessels. Our results showed
that global Spns2 knockout resulted in a mild phenotype of the
retinal vasculature (thin and irregular veins) with decreased
pericyte coverage in the central retina which may be related to
the widely known role of S1P signalling in angiogenesis [76,77].
The milder vascular phenotype in the retina than in the cochlea
may be due to differences in the requirement for Spns2 in these
tissues. We also found focal retinal degeneration in these mutant
eyes suggesting a role for Spns2 in the photoreceptor and/or
retinal pigment epithelium. Taken together, these findings suggest
that SPNS2 is not only a candidate gene for involvement in
deafness, but also for deaf-blind syndromes.
In summary, we report here that Spns2-deficient mice displayed
rapidly progressive hearing impairment associated with a rapid
decline in the EP between P14 and P21. The mechanism by which
Spns2 deficiency leads to decreased EP merits further investiga-
tion, but it most likely involves local S1P signalling. Following the
early drop in the EP, later changes include reduced expression of
key proteins involved in cochlear homeostasis and ultimately
sensory hair cell loss. Our findings suggest that Spns2 is a
promising candidate gene for human deafness. Furthermore,
Spns2-deficient mice may serve as a model to learn more about
the role of S1P signalling in auditory function and the mechanism
underlying at least one form of strial hearing loss.
Materials and Methods
Production and genotyping of Spns2-deficient and
conditional knockout mice
Mouse studies were carried out in accordance with UK Home
Office regulations and the UK Animals (Scientific Procedures) Act
of 1986 (ASPA) under a UK Home Office licence, and the study
was approved by the Wellcome Trust Sanger Institute’s Ethical
Review Committee. Mice were culled using methods approved
under this licence to minimize any possibility of suffering. The
mice were maintained in individually-ventilated cages at a
standard temperature and humidity and in specific pathogen-free
conditions. Either sex was used for this study.
The Spns2 mutant allele we used carries a promoter-driven
cassette designed to interrupt normal gene transcription but
flanked by Frt sites to enable its removal and conversion to a
conditional allele with a critical exon surrounded by LoxP sites (a
knockout-first design; [21,78]). The allele is designated
Spns2tm1a(KOMP)Wtsi, abbreviated to Spns2tm1a in this study. A
schematic of the knockout-first design of Spns2tm1a allele is shown
in Fig. 1A. The mutant mice were generated by blastocyst
injection of the targeted ES cell using standard techniques [20,21]
and germ line transmission of Spns2tm1a was confirmed by a
series of genotyping PCR analyses [79].
The Spns2tm1a colony was maintained on a mixed genetic
C57BL/6BrdTyrc-Brd;C57BL/6Dnk;C57BL/6N background.
Spns2tm1a/tm1a mice were crossed to HprtTg(CMV-Cre)Brd/Wtsi trans-
genic mice (on a C57BL/6NTac background) with systemic
expression of Cre recombinase to remove the cassette and produce
mice carrying the Spns2tm1b allele (Fig. 1A). Mice showing the
correct excision were mated to wildtype C57BL/6N mice and
offspring carrying the Spns2tm1b allele were mated to breed out the
Cre allele and expand the colony. The Spns2tm1c allele was
produced by crossing Spns2tm1a/tm1a mice to Gt(ROSA)26-
Sortm1(FLP1)/Wtsi mice expressing Flp recombinase ubiquitously in
which the promoter-driven cassette was excised and exon 3 was
retained flanked by LoxP sites (Fig. 1A). All the genotyping PCR
primers and product sizes are shown in Table 1. Lack of the rd8
mutant allele was confirmed by conventional sequencing of the
Crb1 gene [33].
Spns2tm1c/tm1c mice were mated to Sox10-Cre mice (Tg(Sox10-
cre)1Wdr) [31] to delete the floxed exon 3 and to generate a
frameshift mutation of Spns2 in the inner ear and craniofacial
neural crest-derived tissues [31]. Genotyping was carried out using
genomic DNA extracted from pinna tissue, which was mosaic
under this conditional knockout strategy, and the conditional
Figure 10. ABR thresholds of mice with Spns2 conditionally
inactivated in different tissues. ABR thresholds of individual mice
are shown. All Cre driver lines showed normal thresholds (left column,
in black. n = number of wildtype; number of mice carrying Cre). Most
control littermates had normal responses (middle column: heterozy-
gotes in blue; wildtypes in green). Homozygous Spns2tm1d mutants (red)
carrying the relevant Cre alleles are shown in the right column.
Spns2tm1d homozygotes carrying the Sox10-Cre allele had raised
thresholds (top right), but the other four Cre lines had normal
thresholds. The bottom row shows equivalent threshold data for the
Spns2tm1c allele and the Flp recombinase line used to generate this
allele, again showing normal thresholds. There were three exceptions of
individuals with raised thresholds (one heterozygote each in Pf4-Cre
cross and Tie1-Cre cross, one homozygote in Tie1-Cre cross), which we
believe probably carry an independent mutation causing the impair-
ment (subject to ongoing positional cloning study).
doi:10.1371/journal.pgen.1004688.g010
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Spns2tm1d allele was confirmed by co-presence of Spns2tm1c and
Sox10-Cre allele PCR bands. Since S1P is released from different
blood cells and endothelial cells, we used mice expressing Tie1-
Cre [80], Pf4-Cre [81], Lyve1-Cre [82] and EpoR-Cre [83] to
inactivate the Spns2 gene in blood vessel endothelial cells,
platelets, lymphatic endothelial cells and red blood cells respec-
tively by crossing with Spns2tm1c/tm1c mice to produce the
conditional knockouts.
Real-time PCR
The organ of Corti, lateral wall (stria vascularis and spiral
ligament), eyes and livers of postnatal day (P)4 homozygous,
heterozygous and wildtype littermate mice were dissected in
RNAlater (n = 3 for each genotype). Total RNA was isolated with
QIAshredder columns (QIAgen, cat. no. 79654) and the RNAeasy
mini kit (QIAgen, cat. no. 74104). RNA was normalized to the
same concentration for cDNA synthesis using oligo dT and
SuperScrip II (Invitrogen). Real-time PCR was performed in
triplicate for each sample using a CFX connect real time PCR
machine (BIO-RAD). The Spns2 probe was designed to cover the
39 untranslated region (Applied Biosystem). Hypoxanthine-gua-
nine phospharibosyltransferase (Hprt) was amplified simultaneous-
ly (Applied Biosystem, Mm01318747_g1) as an internal reference.
The relative quantity of Spns2 was calculated using the 22DDCt
method [84].
Reporter gene visualisation
X-gal staining can be used to visualise the expression of Spns2
due to the LacZ gene inserted in the cassette of Spns2tm1a allele
(Fig. 1A), downstream of the Spns2 promotor. Inner ears of P10
and P14 heterozygous and homozygous mice (at least three mice
of each age group) were dissected out and fixed in 4%
paraformaldehyde (PFA) for 45 minutes to 2 hrs. These were
washed twice with PBS and decalcified in 10% EDTA until soft.
After a PBS wash and immersing in 30% sucrose, inner ears were
embedded in Agarose type VII (low gelling temperature, Sigma-
Aldrich), then mounted using OCT compound ready for
cryosectioning at 14 mm. Sections were treated with Solution A
(2 mM MgCl2; 0.02% NP-40; 0.01% sodium deoxycholate; PBS)
for 15 mins, then incubated with Solution B (Solution A plus
5 mM K3Fe(CN)6; 5 mM K4Fe(CN)6; 1 mg/ml X-Gal in DMSO)
over night at 37uC. Sections were rinsed in water then
counterstained in Fast Red to label nuclei, mounted and
examined.
Auditory Brainstem Response (ABR)
Mice were anaesthetised by ketamine hydrochloride (100 mg/
Kg, Ketaset, Fort Dodge Animal Health) and xylazine hydrochlo-
ride (10 mg/Kg, Rompun, Bayer Animal Health) and subcutane-
ous needle electrodes were inserted on the vertex (active), and over
the left (reference) and right (ground) bullae. A calibrated sound
system was used to deliver free-field click (0.01 ms duration) and
tone pip (various frequencies from 6–30 kHz of 5 ms duration,
1 ms rise/fall time) stimuli at a range of intensity levels in 5 dB
steps. Averaged responses to 256 stimuli, presented at 42.2 per
second, were analysed and thresholds established as the lowest
sound intensity giving a visually-detectable ABR response [85].
For P14 and P21 mice, in order to achieve higher sound pressure
levels, sound was delivered to the external auditory meatus via a
parabolic cone loud speaker attachment for click (0.01 ms
duration) and tone pip stimuli (frequencies from 3–42 kHz of
5 ms duration in 3 dB SPL steps). Separate cohorts of P14 and
P21 Spns2tm1a mice were used at the standard maximum intensity
of 95 dB SPL with free field delivery as shown in Fig. 11 and at
the higher sound intensities delivered near field, directly to the
external auditory meatus in Fig. 1. The median ABR thresholds
Figure 11. The hearing loss of Spns2tm1a/tm1a, Spns2tm1b/tm1b and Spns2tm1d/tm1d; Sox10-Cre mice showed a similar pattern of
progression. ABR thresholds of individual homozygotes (red), heterozygotes (blue) and wildtypes (green) are shown at 2, 3 and 14 or 4–10 weeks
old. The control mice had immature thresholds at 2 weeks old and continued to mature to normal hearing levels at 3 weeks old. Spns2tm1a/tm1a and
Spns2tm1d/tm1d; Sox10-Cre mice displayed progressive hearing loss from 2 to 3 weeks old. The red line in the middle bottom panel represents a control
mouse homozygous for Spns2tm1c but without carrying Sox10-Cre, and thus had no conditional knockout of Spns2 in the inner ear and normal
hearing.
doi:10.1371/journal.pgen.1004688.g011
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recorded in homozygous mutants at P14 and P21 shown in Fig. 1
were compared using the Kruskall-Wallis One-Way Analysis of
Variance on Ranks, as thresholds did not show a normal
distribution.
Scanning electron microscopy and gross morphology of
ears
The temporal bones were isolated. The inner ears were
dissected out and fixed by 2.5% glutaraldehyde in 0.1M sodium
cacodylate buffer with 3 mM calcium chloride at room temper-
ature for 3 hours. Cochleae were finely dissected in PBS. This was
followed by further processing using an osmium-thiocarbohydra-
zide-osmium (OTOTO) method [86]. The samples were dehy-
drated in increasing concentrations of ethanol, critical-point dried
(Bal-Tec CPD030), mounted and examined under a HITACHI S-
4800 scanning electron microscope. At least 3 wildtype, hetero-
zygous and homozygous mice were examined for each age group
(P4, P21, P28 and P56). Middle ears were dissected and examined.
Inner ears were cleared by a standard glycerol clearing technique
and examined for gross structural defects (control, n = 5;
homozygotes, n = 5; aged P30–34).
Semi-thin sections and transmission electron microscopy
Inner ears (wildtype, n= 2; heterozygotes, n = 2; homozygotes,
n = 4, at P28) were dissected out and gently perfused with 2.5%
glutaraldehyde, 1% paraformaldehyde in 0.1M sodium phosphate
buffer with 0.8 mM calcium chloride through the round and oval
windows and a small hole in the apex then fixed at room
temperature for 2 hours. Secondary fixation was in 1% osmium
tetroxide in sodium phosphate buffer for 1 hour. After 5 washes in
0.1 M sodium phosphate buffer, inner ears were decalcified in
0.1M EDTA at 4uC until soft. Then the samples were dehydrated
through an ethanol series, staining in 2% uranyl acetate at the
30% ethanol stage, embedded in Epon resin mixed 1:1 and then
3:1 in propylene oxide for 30 min and infiltrated overnight under
vacuum in neat resin. The samples were embedded at 60uC for
24–48 hours. 1 mm sections were cut through the modiolar plane
and stained with toluidine blue for light microscope observation.
60 nm sections were cut on a Leica EM UC6 ultramicrotome,
stained in 2% uranyl acetate and aqueous lead citrate and imaged
on an FEI Spirit Biotwin 120 kV transmission electron microscope
using a Tietz F4.15 CCD.
Endocochlear potential measurement
Mice were anaesthetized with 0.01 ml/g body weight of 20%
urethane, a tracheal cannula was inserted and the bulla was
opened to reveal the cochlea while the body temperature was kept
at 37uC by a feedback-controlled heating pad. A small hole was
made in the bony wall of the cochlea over the basal turn of scala
media, and a micropipette electrode filled with 150 mM potassium
chloride was advanced through the hole and through the lateral
wall into the scala media. The potential difference between the
scala media and a reference silver/silver chloride pellet under the
dorsal skin was recorded [24].
Surface preparation of lateral wall and visualization of
capillaries
The inner ears were rapidly dissected out and fixed in 4%
paraformaldehyde at room temperature for 2 hours. The lateral
walls were dissected out in PBS for surface preparation.
Filamentous actin was visualized by rhodamine phalloidin
(1:200, Molecular Probe) at room temperature for 2 hours. Strial
capillaries were visualized by Isolectin B4 (Vector Laboratories,
1:50) at 4uC, overnight in PBS with 10% sheep serum). Samples
were mounted with Vectashield Mounting medium (Vector, Cat.
No: H-1000) and imaged by confocal microscopy (Carl Zeiss,
LSM 510 META). The numbers of capillary branch points per
field (2206220-mm fields) in the middle turn (40–70% of the
Figure 12. Eye defects in Spns2tm1a/tm1a mice. A–C, Phenotype
screening was performed on 15 week old Spns2tm1a/tm1a mice and
identified buphthalmos, corneal opacity with vascularization and
possible ulceration (B) and corneal opacity with vascularisation and
polyp, thick discharge, elongated pupil which did not fully dilate with
tropicamide (C). Albino mice were selected to achieve clearer
demonstration, and a wildtype is shown in (A). D, Pupil-optic nerve
section of a 15 week old wildtype eye. E, The Spns2tm1a/tm1a mice
showed a grossly abnormal eye with corneal opacity, vascularization,
collapsed anterior chamber, small cataractous lens, and focal retinal
degeneration. c = cornea, ac = anterior chamber, pc =posterior cham-
ber, on= optic nerve. Scale bar = 450 mm. F,G,H,I Analysis of retinal
vasculature was performed on retinal wholemounts from P10 pups
(F,G) and 8 week old adult mice(H,I). Retinal vasculature was stained
with Isolectin B4 (green) to visualise the endothelium and Proteoglycan
NG2 (red) to visualise pericytes. Whereas arteries (a) appeared
morphologically normal, veins (v) appeared thinner in Spns2tm1a/tm1a
(I) than in Spns2+/tm1a (H) and had an irregular caliber with regions of
narrowing (arrows). Although the retina has three capillary plexi only
the primary plexus is shown at both P10 and 8 weeks as this is the first
plexus to form and mature. Scalebars: 50 mm. J, Branch point analysis
was performed on P10 retinal vasculature (F,G) to determine whether
retinal vasculature showed any developmental abnormalities in vascular
patterning. No significant difference was detected between Spns2tm1a/
tm1a (red) and Spns2+/tm1a (blue) mice in the central retina (mature
vessels) or the periphery, where the vessels are still developing at P10,
in either the arteries or veins (Mann-Whitney U test for central branch
points, p = 0.69; t-test for peripheral branch points, arterial p = 0.899,
venous p = 0.996).
doi:10.1371/journal.pgen.1004688.g012
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distance along the cochlear duct from the base) of the stria
vascularis (control, n = 4; homozygotes, n = 5, at P14. control,
n = 3; homozygotes, n = 5, at P28) was quantified using image J.
Data were presented as a density in a 1006100 mm field and
statistics analysis was conducted using Mann-Whitney Rank Sum
Test, SigmaPlot v12.0. Surface preparations were also used for
analysis of Kcnq1 expression, using overnight incubation at 4uC
with goat anti-Kcnq1 polyclonal antibody (Santa Cruz, 1:200)
followed by washing with PBS and incubation with donkey anti-
goat secondary antibody (Invitrogen, 1:500) prior to analysis by
confocal microscopy. At least three homozygotes and three
controls were used at P14, P28 and 6 months for phalloidin
labeling to show marginal cell boundaries, and P14 and 5–6 weeks
for Kcnq1 expression. The density of marginal cells was measured
in the phalloidin-labelled whole mount preparations by counting
the number of cells defined by their labeled boundaries in two
areas each 1006100 mm from the middle turn (40–70%) of each
cochlea (n = 4 homozygous mutants; 4 littermate controls).
Immunofluorescence labeling
The cochleae were dissected out and fixed in 4% PFA at room
temperature for 2 hours. Cryosections were obtained as described
above for X-gal staining. We used the following antibodies: rabbit
anti-Kcnj10 polyclonal (Alomone labs, 1:300), rabbit anti-Gjb2
polyclonal (from WH Evans, 1:300), rabbit anti-Gjb6 polyclonal
(Zymed, 1:400), mouse anti- Na+, K+-ATPase (a1 subunit)
monoclonal (Sigma, 1:300), mouse anti- NKCC1 monoclonal
(C. Lytle, Developmental Studies Hybridoma Bank, University of
Iowa, 1:300) and rabbit anti-ZO-1 polyclonal (Zymed, 1:300).
Sections were blocked by incubation with 10% sheep serum (with
0.1% TritonX-100 in PBS) for 40 mins. Sections were incubated
with appropriate primary antibodies overnight at 4uC, washed
with PBS and incubated with corresponding secondary antibodies
at room temperature for 2 hours (donkey anti-rabbit, donkey anti-
goat, Invitrogen, 1:500). After washing with PBS, slides were
imaged by confocal microscopy. Three mice of each genotype
(Spns2tm1a/tm1a and Spns2+/+) were used for each antibody at P14
and 5–6 weeks old.
Stria vascularis tight junction permeability assessment
The inner ears (wildtype, n = 1; heterozygote, n= 3; homozy-
gote, n = 4 at 6 weeks old) were dissected and round and oval
windows were opened in PBS containing 1 mM calcium chloride.
A hole was made in the basal turn leading to the scala media. The
membranous labyrinth was perfused for 5 minutes with 400 ml
Sulfo-NHS-LC-Biotin (Thermo Scientific, 10 mg/ml, in PBS with
1 mM calcium chloride) through the round and oval windows and
the hole exposing the endolymphatic compartment. Following a
PBS wash, the inner ears were fixed in 4% paraformaldehyde at
room temperature for 2 hours, and processed for cryosectioning as
described above. The biotin tracer was detected by fluorescein
isothiocyanate (FITC)-conjugated streptavidin (Thermo Scientific,
1:100) incubating at room temperature for 30 min. Samples
perfused with PBS alone were used as negative controls.
Strial capillary permeability assessment
Mice (wildtype, n= 2; heterozygote, n= 2; homozygote, n= 2;
at 5–6 weeks old) were warmed in a 39uC incubator for 5 minutes
and then held in a mouse restrainer so that the tail was accessible
and the tail vein visible. A 50 ml aliquot of 5% (w/v) FITC-
conjugated bovine serum albumin (BSA-FITC; Sigma cat.
no. A9771; size 66.4 kDa), made up in sterile PBS, was injected
into the tail vein. The mice were left at room temperature for 45–
60 minutes to allow the BSA-FITC to permeate all capillaries and
to allow for any vascular extravasation. The mice were sacrificed
by CO2 inhalation and the auditory bullae dissected out. Whole
cochleae were exposed and fixed by removing a small piece of
bone at the apex and gently perfusing 4% PFA through the round
and oval windows. Cochleae were then immersed in fixative and
left on a rotator for 1.5 hours at room temperature. Whole-mounts
Table 1. Primers for genotyping.
Genotyping PCR Primer Forward (59 to 39 order) Primer Reverse (59 to 39 order)
Product Size (base
pairs, bp)
Spns2 wildtype CAAAACAATATGGGCTGGGG GATGAAGGCAGGACTCAGGG 363
Spns2tm1c CAAAACAATATGGGCTGGGG GATGAAGGCAGGACTCAGGG approx. 470
Spns2tm1a CAAAACAATATGGGCTGGGG TCGTGGTATCGTTATGCGCC 187
Spns2tm1d CAAAACAATATGGGCTGGGG TCGTGGTATCGTTATGCGCC 187
LacZ ATCACGACGCGCTGTATC ACATCGGGCAAATAATATCG Wildtype:absent;
Mutant:approx. 180
Neo CAAGATGGATTGCACGCAGGTTCTC GACGAGATCCTCGCCGTCGGGCATGCGCGCC Wildtype:absent;
Mutant:approx. 700
Sox10-Cre GCGGTCTGGCAGTAAAAACTATC GTGAAACAGCATTGCTGTCACTT Wildtype:absent;
Mutant:approx. 100
Lyve1 Cre wildtype TGCCACCTGAAGTCTCTCCT TGAGCCACAGAAGGGTTAGG 425
Lyve1 Cre mutant GAGGATGGGGACTGAAACTG TGAGCCACAGAAGGGTTAGG 210
Epor Cre wildtype CAGGAATTCAAGCTCAACCTCA GGCAGCCTGGGCACCTTCAC 431
Epor Cre mutant CAGGAATTCAAGCTCAACCTCA GTGTGGCTGCCCCTTCTGCCA 679
Tie1 Cre GATGCCGGTGAACGTGCAAAACAGGCTC CGCCGTAAATCAATCGATGAGTTGCTTC Wildtype:absent; Mutant:
approx. 400
Pf4 Cre wildtype CAAATGTTGCTTGTCTGGTG GTCAGTCGAGTGCACAGTTT 200
Pf4 Cre mutant CCCATACAGCACACCTTTTG TGCACAGTCAGCAGGTT 450
doi:10.1371/journal.pgen.1004688.t001
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of stria vascularis were dissected from fixed cochleae, covered with
Vectashield Mounting Media (Vector, Cat. No: H-1000) in glass
bottom culture dishes (MatTek Corp.) and imaged using confocal
laser-scanning microscopy (Carl Zeiss, LSM 510 META).
Ocular assessment
Mice underwent ophthalmic screening at 15 weeks of age. They
were assessed for gross morphological changes to the eye using a
slit lamp (Zeiss SL130) and ophthalmoscope (Heine Omega 500).
The eye was examined both undilated and dilated (topical
tropicamide). Images using the slit lamp were collected using a
Leica DFC420 camera. The mice were culled under terminal
anaesthesia followed by cervical dislocation and both eyes from 3
male homozygous mutants and 3 wildtype mice were removed and
fixed. Pupil-optic nerve sections were processed, stained with
hematoxylin and eosin, and standard images were captured under
light microscopy for review [87].
For whole mount retinal analysis, heterozygotes and homozy-
gotes were used (n= 3 for each genotype at P10, n= 2 at 8 weeks
old) and the eyes removed and fixed in 4% PFA. Retinae were
prepared and stained as described [88] using flourescein-conju-
gated Griffonia simplicifolia Isolectin B4 (Vector Laboratories,
UK) to label blood vessels, mouse anti-proteoglycan NG2
(Millipore UK Ltd., UK) to label pericytes, and donkey anti-
rabbit secondary Alexa-594 (Molecular Probes, Life Technologies,
UK). The homozygote and control mouse retinae were stained in
the same well to control for changes in staining efficiency,
distinguishing the retinae by different numbers of radial incisions.
All tissues were mounted in Vectashield (Vector Laboratories Ltd.,
Peterborough, UK), imaged by confocal microscopy (Nikon A1R;
Nikon Instruments, Inc., Melville, NY), and maximum intensity
projections of z-stacks were created using NisElements AR Version
4.0 software (Nikon UK, Kingston Upon Thames, UK). The
MetaMorph Angiogenesis Tube Formation application (Molecular
Devices, Berkshire, UK) was used for quantification. Confocal
images were used to determine the total area covered by vessels
and by pericytes to calculate the percentage pericyte coverage of
vessels and the total number of capillary branchpoints per unit
area. We imaged three areas of each retina: three different regions
of the central retina each encompassing an artery and vein, and
two images each of peripheral arteries and peripheral veins, a total
of five images/retina. Threshold values were kept the same for
analysis of samples of the same stage.
Supporting Information
Figure S1 Spns2 expression in the vestibular system, normal
gross structure of inner ears and normal organ of Corti at P4. A,B:
X-gal staining showed expression of Spns2 in the vestibular system
at P10. Labelling (blue) was detected in the cristae (A, arrow) and
maculae (utricular macula shown here) (B, arrow). Scale bar:
20 mm. C,D: Cleared inner ears showed no apparent differences
in gross structure between Spns2 homozygous mutants and
controls at 4 weeks old. Scale bar: 1 mm. E,F: Scanning electron
microscopy showed no abnormalities of the surface of the organ of
Corti at P4 in the Spns2 homozygous mutants compared with
littermate controls. Scale bar: 10 mm.
(TIF)
Figure S2 Whole-mount stria vascularis examination. A,B:
Confocal images focussed at the level of the basal cell boundaries,
visualised by phalloidin staining (red). No obvious change was seen
in Spns2 homozygous mutants at 4 weeks old. Scale bar: 10 mm.
C,D: The stria vascularis showed dilated and tortuous capillaries
with increased branch points in all five Spns2 homozygous
mutants studied at 4 weeks old. Strial capillaries were visualised by
isolectin B4 (green). Scale bar: 50 mm. E,F: Strial hyperpigmen-
tation was pronounced in older mutants. A seven month old Spns2
homozygous mutant (F) had obvious accumulation of pigment in
the stria vascularis. Scale bar: 20 mm.
(TIF)
Figure S3 Normal expression of Na+/K+-ATPase, NKCC1 and
ZO-1 in lateral wall and Kcnj10 in spiral ganglion at 5–6 weeks.
Na+/K+-ATPase (red) labelling in stria vascularis and type II
fibrocytes in Spns2 homozygous mutants (A) was comparable with
that of controls (B). Notice absence of Gjb2 labelling in the type II
fibrocytes in the mutants. NKCC1 (red) labelling in the Spns2
homozygous mutants was located in stria vascularis and type II
fibrocytes and appeared similar in the controls (C, D). ZO-1
(green) labelling was present in the basal cells of the stria in both
Spns2 homozygous mutants and controls (E,F). G,H: Acetylated
a-tubulin (red) labelled spiral ganglion neurons and Kcnj10 (green)
labelled satellite cells. Kcnj10 expression in Spns2 homozygous
mutants was present and comparable with controls, suggesting that
the reduced Kcnj10 labelling observed in the stria (see Fig. 8) was
tissue-specific. Scale bar: 20 mm in A–H.
(TIF)
Figure S4 Pericyte coverage of retinal blood vessels and open
eyelids at birth. A: Analysis of the percentage of pericyte coverage
of the retinal blood vessels revealed a significantly reduced
coverage in the mutants in the central retina (t-test for central
vessels; p = 0.015), but no significant difference in coverage of the
peripheral vessels (arterial and venous) (Mann-Whitney Rank Sum
Test for peripheral arterial vessels, p = 0.151; t-test for peripheral
venous vessels, p = 0.284) between the Spns2 mutant homozygotes
and heterozygous controls at P10. B: Spns2tm1a homozygous
mutants displayed open eyelids at birth.
(TIF)
Acknowledgments
We thank the Wellcome Trust Sanger Institute’s Mouse Genetics Project
for generating the Spns2tm1a and Spns2tm1b mutant mice for screening,
Selina Pearson and Rosalind Lacey for assistance with ABR measurements,
Zahra Hance for assistance with genotyping and TEM sectioning, Valerie
E Vancollie for providing images of the eye, Carl Hobbs and Philipp
Suetterlin for advice on X-gal staining, MaryAnn Mahajan for ocular
histopathology analysis, Allan Bradley and Haydn Prosser for providing the
HprtTg(CMV-Cre)Brd and Gt(ROSA)26Sortm1(FLP1)/Wtsi lines, William Rich-
ardson for providing the Sox10- Cre line, and Ursula Klingmuller for
providing the Epor-Cre line.
Author Contributions
Conceived and designed the experiments: JC NI AN IJJ JKW AF DJ KPS.
Performed the experiments: JC NI JK SJ DG JP JKW. Analyzed the data:
JC NI JK SJ JP VBM SHT IJJ JKW AF DJ KPS. Wrote the paper: JC
KPS.
References
1. Fukuhara S, Simmons S, Kawamura S, Inoue A, Orba Y, et al. (2012) The
sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells
regulates lymphocyte trafficking in mice. J Clin Invest 122: 1416–1426.
2. Mendoza A, Breart B, Ramos-Perez WD, Pitt LA, Gobert M, et al. (2012) The
transporter spns2 is required for secretion of lymph but not plasma sphingosine-
1-phosphate. Cell Rep 2: 1104–1110.
Spns2 Deficiency Causes Hearing Loss
PLOS Genetics | www.plosgenetics.org 15 October 2014 | Volume 10 | Issue 10 | e1004688
3. Hisano Y, Kobayashi N, Yamaguchi A, Nishi T (2012) Mouse SPNS2 functions
as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS One
7: e38941.
4. Nijnik A, Clare S, Hale C, Chen J, Raisen C, et al. (2012) The role of
sphingosine-1-phosphate transporter spns2 in immune system function.
J Immunol 189: 102–111.
5. Nagahashi M, Kim EY, Yamada A, Ramachandran S, Allegood JC, et al. (2012)
Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood
and lymph levels and the lymphatic network. FASEB J 27:1001–11
6. Kawahara A, Nishi T, Hisano Y, Fukui H, Yamaguchi A, et al. (2009) The
Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial
Precursors. Science 323: 524–527.
7. Zhang H, Desai NN, Olivera A, Seki T, Brooker G, et al. (1991) Sphingosine-1-
phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 114: 155–
167.
8. Olivera A, Spiegel S (1993) Sphingosine-1-phosphate as second messenger in cell
proliferation induced by PDGF and FCS mitogens. Nature 365: 557–560.
9. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, et al. (1996)
Suppression of ceramide-mediated programmed cell death by sphingosine-1-
phosphate. Nature 381: 800–803.
10. Wang F, Van Brocklyn JR, Hobson JP, Movafagh S, Zukowska-Grojec Z, et al.
(1999) Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled
cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274:
35343–35350.
11. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, et al. (1999) Vascular
endothelial cell adherens junction assembly and morphogenesis induced by
sphingosine-1-phosphate. Cell 99: 301–312.
12. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, et al. (2000) Edg-1, the G
protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular
maturation. J Clin Invest 106: 951–961.
13. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, et al. (2001) Sphingosine
1-phosphate promotes endothelial cell barrier integrity by Edg-dependent
cytoskeletal rearrangement. J Clin Invest 108: 689–701.
14. Kupperman E, An S, Osborne N, Waldron S, Stainier DY (2000) A sphingosine-
1-phosphate receptor regulates cell migration during vertebrate heart develop-
ment. Nature 406: 192–195.
15. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, et al. (2002) The
immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol
Chem 277: 21453–21457.
16. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, et al. (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor
agonists. Science 296: 346–349.
17. Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, et al. (2008) Vascular
endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102:
669–676.
18. Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, et al. (2007)
Promotion of lymphocyte egress into blood and lymph by distinct sources of
sphingosine-1-phosphate. Science 316: 295–298.
19. Venkataraman K, Thangada S, Michaud J, Oo ML, Ai Y, et al. (2006)
Extracellular export of sphingosine kinase-1a contributes to the vascular S1P
gradient. Biochem J 397: 461–471.
20. White JK, Gerdin AK, Karp NA, Ryder E, Buljan M, et al. (2013) Genome-
wide Generation and Systematic Phenotyping of Knockout Mice Reveals New
Roles for Many Genes. Cell 154: 452–464.
21. Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, et al. (2011) A
conditional knockout resource for the genome-wide study of mouse gene
function. Nature 474: 337–342.
22. Steel KP, Bock GR (1983) Cochlear dysfunction in the jerker mouse. Behav
Neurosci 97: 381–391.
23. Tasaki I, Spyropoulos CS (1959) Stria vascularis as source of endocochlear
potential. J Neurophysiol 22: 149–155.
24. Steel KP, Barkway C (1989) Another role for melanocytes: their importance for
normal stria vascularis development in the mammalian inner ear. Development
107: 453–463.
25. Allt G, Lawrenson JG (2001) Pericytes: cell biology and pathology. Cells Tissues
Organs 169: 1–11.
26. Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and
maintenance. Neuro Oncol 7: 452–464.
27. Cable J, Steel KP (1991) Identification of two types of melanocyte within the
stria vascularis of the mouse inner ear. Pigment Cell Res 4: 87–101.
28. Jabba SV, Oelke A, Singh R, Maganti RJ, Fleming S, et al. (2006) Macrophage
invasion contributes to degeneration of stria vascularis in Pendred syndrome
mouse model. BMC Med 4: 37.
29. Zhang W, Dai M, Fridberger A, Hassan A, Degagne J, et al. (2012) Perivascular-
resident macrophage-like melanocytes in the inner ear are essential for the
integrity of the intrastrial fluid-blood barrier. Proc Natl Acad Sci U S A 109:
10388–10393.
30. Spicer SS, Schulte BA (1991) Differentiation of inner ear fibrocytes according to
their ion transport related activity. Hear Res 56: 53–64.
31. Matsuoka T, Ahlberg PE, Kessaris N, Iannarelli P, Dennehy U, et al. (2005)
Neural crest origins of the neck and shoulder. Nature 436: 347–355.
32. Bassett JH, Gogakos A, White JK, Evans H, Jacques RM, et al. (2012) Rapid-
throughput skeletal phenotyping of 100 knockout mice identifies 9 new genes
that determine bone strength. PLoS Genet 8: e1002858.
33. Mattapallil MJ, Wawrousek EF, Chan CC, Zhao H, Roychoudhury J, et al.
(2012) The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/
6N mice and embryonic stem cells, and confounds ocular induced mutant
phenotypes. Invest Ophthalmol Vis Sci 53: 2921–2927.
34. Salt AN, Melichar I, Thalmann R (1987) Mechanisms of endocochlear potential
generation by stria vascularis. Laryngoscope 97: 984–991.
35. Minowa O, Ikeda K, Sugitani Y, Oshima T, Nakai S, et al. (1999) Altered
cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science
285: 1408–1411.
36. Marcus DC, Wu T, Wangemann P, Kofuji P (2002) KCNJ10 (Kir4.1) potassium
channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol
282: C403–407.
37. Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, et al. (2004) Loss of
KCNJ10 protein expression abolishes endocochlear potential and causes
deafness in Pendred syndrome mouse model. BMC Med 2: 30.
38. Rickheit G, Maier H, Strenzke N, Andreescu CE, De Zeeuw CI, et al. (2008)
Endocochlear potential depends on Cl- channels: mechanism underlying
deafness in Bartter syndrome IV. Embo J 27: 2907–2917.
39. Norgett EE, Golder ZJ, Lorente-Canovas B, Ingham N, Steel KP, et al. (2012)
Atp6v0a4 knockout mouse is a model of distal renal tubular acidosis with
hearing loss, with additional extrarenal phenotype. Proc Natl Acad Sci U S A
109: 13775–13780.
40. Kitajiri S, Miyamoto T, Mineharu A, Sonoda N, Furuse K, et al. (2004)
Compartmentalization established by claudin-11-based tight junctions in stria
vascularis is required for hearing through generation of endocochlear potential.
J Cell Sci 117: 5087–5096.
41. Cohen-Salmon M, Ott T, Michel V, Hardelin JP, Perfettini I, et al. (2002)
Targeted ablation of connexin26 in the inner ear epithelial gap junction network
causes hearing impairment and cell death. Curr Biol 12: 1106–1111.
42. Cohen-Salmon M, Regnault B, Cayet N, Caille D, Demuth K, et al. (2007)
Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within
the cochlear stria vascularis. Proceedings of the National Academy of Sciences
104: 6229–6234.
43. Teubner B, Michel V, Pesch J, Lautermann J, Cohen-Salmon M, et al. (2003)
Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of
endocochlear potential. Hum Mol Genet 12: 13–21.
44. Ohlemiller KK, Rice ME, Gagnon PM (2008) Strial microvascular pathology
and age-associated endocochlear potential decline in NOD congenic mice. Hear
Res 244: 85–97.
45. Ohlemiller KK (2009) Mechanisms and genes in human strial presbycusis from
animal models. Brain Res 1277: 70–83.
46. Lu MH, Takemoto M, Watanabe K, Luo H, Nishimura M, et al. (2012)
Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes
hearing impairments in mice. J Physiol 590: 4029–4044.
47. Mustapha M, Fang Q, Gong TW, Dolan DF, Raphael Y, et al. (2009) Deafness
and permanently reduced potassium channel gene expression and function in
hypothyroid Pit1dw mutants. J Neurosci 29: 1212–1223.
48. Schuknecht HF, Gacek MR (1993) Cochlear pathology in presbycusis. Ann Otol
Rhinol Laryngol 102: 1–16.
49. Steel KP (1995) Inherited hearing defects in mice. Annu Rev Genet 29: 675–
701.
50. Gow A, Davies C, Southwood CM, Frolenkov G, Chrustowski M, et al. (2004)
Deafness in Claudin 11-null mice reveals the critical contribution of basal cell
tight junctions to stria vascularis function. J Neurosci 24: 7051–7062.
51. Steel KP, Barkway C, Bock GR (1987) Strial dysfunction in mice with cochleo-
saccular abnormalities. Hear Res 27: 11–26.
52. Levkau B (2008) Sphingosine-1-phosphate in the regulation of vascular tone: a
finely tuned integration system of S1P sources, receptors, and vascular
responsiveness. Circ Res 103: 231–233.
53. Scherer EQ, Lidington D, Oestreicher E, Arnold W, Pohl U, et al. (2006)
Sphingosine-1-phosphate modulates spiral modiolar artery tone: A potential role
in vascular-based inner ear pathologies? Cardiovasc Res 70: 79–87.
54. Kono M, Belyantseva IA, Skoura A, Frolenkov GI, Starost MF, et al. (2007)
Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem
282: 10690–10696.
55. Cable J, Steel KP (1998) Combined cochleo-saccular and neuroepithelial
abnormalities in the Varitint-waddler-J (VaJ) mouse. Hear Res 123: 125–136.
56. Ohlemiller KK, Lett JM, Gagnon PM (2006) Cellular correlates of age-related
endocochlear potential reduction in a mouse model. Hear Res 220: 10–26.
57. Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, et al. (2009)
Sphingosine-1-phosphate in the plasma compartment regulates basal and
inflammation-induced vascular leak in mice. J Clin Invest 119: 1871–1879.
58. Wang L, Dudek SM (2009) Regulation of vascular permeability by sphingosine
1-phosphate. Microvasc Res 77: 39–45.
59. McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, et al. (2004)
Sphingosine 1-phosphate reduces vascular leak in murine and canine models of
acute lung injury. Am J Respir Crit Care Med 170: 987–993.
60. Spicer SS, Schulte BA (2005) Pathologic changes of presbycusis begin in
secondary processes and spread to primary processes of strial marginal cells.
Hear Res 205: 225–240.
61. Ohlemiller KK, Rice ME, Lett JM, Gagnon PM (2009) Absence of strial
melanin coincides with age-associated marginal cell loss and endocochlear
potential decline. Hear Res 249: 1–14.
Spns2 Deficiency Causes Hearing Loss
PLOS Genetics | www.plosgenetics.org 16 October 2014 | Volume 10 | Issue 10 | e1004688
62. Chen J, Nathans J (2007) Estrogen-related receptor beta/NR3B2 controls
epithelial cell fate and endolymph production by the stria vascularis. Dev Cell
13: 325–337.
63. Lee JH, Kim SJ, Jung SJ, Lim W, Kim KW, et al. (2000) Voltage-dependent K
(+) currents in spiral prominence epithelial cells of rat cochlea. Hear Res 146: 7–
16.
64. Royaux IE, Belyantseva IA, Wu T, Kachar B, Everett LA, et al. (2003)
Localization and functional studies of pendrin in the mouse inner ear provide
insight about the etiology of deafness in pendred syndrome. J Assoc Res
Otolaryngol 4: 394–404.
65. Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, et al. (2001)
Targeted disruption of mouse Pds provides insight about the inner-ear defects
encountered in Pendred syndrome. Hum Mol Genet 10: 153–161.
66. Spicer SS, Schulte BA (1996) The fine structure of spiral ligament cells relates to
ion return to the stria and varies with place-frequency. Hear Res 100: 80–100.
67. Schulte BA, Adams JC (1989) Distribution of immunoreactive Na+,K+-ATPase
in gerbil cochlea. J Histochem Cytochem 37: 127–134.
68. Crouch JJ, Sakaguchi N, Lytle C, Schulte BA (1997) Immunohistochemical
localization of the Na-K-Cl co-transporter (NKCC1) in the gerbil inner ear.
J Histochem Cytochem 45: 773–778.
69. Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-
phosphate signaling and its role in disease. Trends Cell Biol 22: 50–60.
70. Adada M, Canals D, Hannun YA, Obeid LM (2013) Sphingosine-1-phosphate
receptor 2. FEBS J.
71. Herr DR, Grillet N, Schwander M, Rivera R, Muller U, et al. (2007)
Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells
mainly via activation of S1P2. J Neurosci 27: 1474–1478.
72. MacLennan AJ, Benner SJ, Andringa A, Chaves AH, Rosing JL, et al. (2006)
The S1P2 sphingosine 1-phosphate receptor is essential for auditory and
vestibular function. Hear Res 220: 38–48.
73. Ishii M, Kikuta J, Shimazu Y, Meier-Schellersheim M, Germain RN (2010)
Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and
bone remodeling in vivo. J Exp Med 207: 2793–2798.
74. Breuskin I, Bodson M, Thelen N, Thiry M, Borgs L, et al. (2009) Sox10
promotes the survival of cochlear progenitors during the establishment of the
organ of Corti. Dev Biol 335: 327–339.
75. Wakaoka T, Motohashi T, Hayashi H, Kuze B, Aoki M, et al. (2013) Tracing
Sox10-expressing cells elucidates the dynamic development of the mouse inner
ear. Hear Res 302: 17–25.
76. Jung B, Obinata H, Galvani S, Mendelson K, Ding BS, et al. (2012) Flow-
regulated endothelial S1P receptor-1 signaling sustains vascular development.
Dev Cell 23: 600–610.
77. Mendelson K, Zygmunt T, Torres-Vazquez J, Evans T, Hla T (2013)
Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular
patterning. J Biol Chem 288: 2143–2156.
78. Testa G, Schaft J, van der Hoeven F, Glaser S, Anastassiadis K, et al. (2004) A
reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles.
Genesis 38: 151–158.
79. Ryder E, Gleeson D, Sethi D, Vyas S, Miklejewska E, et al. (2013) Molecular
Characterization of Mutant Mouse Strains Generated from the EUCOMM/
KOMP-CSD ES Cell Resource. Mamm Genome 24: 286–294.
80. Gustafsson E, Brakebusch C, Hietanen K, Fassler R (2001) Tie-1-directed
expression of Cre recombinase in endothelial cells of embryoid bodies and
transgenic mice. J Cell Sci 114: 671–676.
81. Tiedt R, Schomber T, Hao-Shen H, Skoda RC (2007) Pf4-Cre transgenic mice
allow the generation of lineage-restricted gene knockouts for studying
megakaryocyte and platelet function in vivo. Blood 109: 1503–1506.
82. Pham TH, Baluk P, Xu Y, Grigorova I, Bankovich AJ, et al. (2010) Lymphatic
endothelial cell sphingosine kinase activity is required for lymphocyte egress and
lymphatic patterning. J Exp Med 207: 17–27.
83. Heinrich AC, Pelanda R, Klingmuller U (2004) A mouse model for visualization
and conditional mutations in the erythroid lineage. Blood 104: 659–666.
84. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
85. Ingham NJ, Pearson S, Steel KP (2011) Using the auditory brainstem response
(ABR) to determine sensitivity of hearing in mutant mice. Current Protocols in
Mouse Biology 1: 279–287.
86. Hunter-Duvar IM (1978) A technique for preparation of cochlear specimens for
assessment with the scanning electron microscope. Acta Otolaryngol Suppl 351:
3–23.
87. Mahajan VB, Skeie JM, Assefnia AH, Mahajan M, Tsang SH (2011) Mouse eye
enucleation for remote high-throughput phenotyping. J Vis Exp 2011: pii: 3184
88. West H, Richardson WD, Fruttiger M (2005) Stabilization of the retinal vascular
network by reciprocal feedback between blood vessels and astrocytes.
Development 132: 1855–1862.
Spns2 Deficiency Causes Hearing Loss
PLOS Genetics | www.plosgenetics.org 17 October 2014 | Volume 10 | Issue 10 | e1004688
